Natalia Marlowe
About
In The Last Decade
Natalia Marlowe
15 papers receiving 428 citations
Peers
Comparison fields: 5 of 53
- Virology 324
- Infectious Diseases 316
- Molecular Biology 81
- Epidemiology 72
- Genetics 68
Countries citing papers authored by Natalia Marlowe
This map shows the geographic impact of Natalia Marlowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Marlowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Marlowe more than expected).
Fields of papers citing papers by Natalia Marlowe
This network shows the impact of papers produced by Natalia Marlowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Marlowe. The network helps show where Natalia Marlowe may publish in the future.
Co-authorship network of co-authors of Natalia Marlowe
This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Marlowe. A scholar is included among the top collaborators of Natalia Marlowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Marlowe. Natalia Marlowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 11 | |
| 3 | 6 | |
| 4 | 75 | |
| 5 | 5 | |
| 6 | 37 | |
| 7 | 23 | |
| 8 | 9 | |
| 9 | 8 | |
| 10 | 47 | |
| 11 | 27 | |
| 12 | 66 | |
| 13 | In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy. | 16 |
| 14 | PERFORMANCE OF THE NEW VIROSEQ ™ HIV-1 GENOTYPING SYSTEM (VERSION 2) WITH GROUP M SUBTYPE PANEL AND WITH SUBTYPE B CLINICAL RESEARCH SAMPLES AT TEST SITES | 3 |
| 15 | 113 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.